TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Protista Biotechnology AB
Closing information (x1000 EUR)
| Closing information | 2015/12 | 2014/12 | 2013/12 |
| Turnover |
0
|
1
|
0 |
| Financial expenses |
0
|
531
|
7 |
| Earnings before taxes |
-131
|
-619
|
-189 |
| EBITDA |
-77
|
-88
|
-176 |
| Total assets |
92
|
143
|
1,129 |
| Current assets |
2
|
5
|
1,034 |
| Current liabilities |
111
|
107
|
958 |
| Equity capital |
-93
|
36
|
13 |
| - share capital |
11
|
11
|
11 |
| Employees (average) |
0
|
1
|
1 |
Financial ratios
| Fiscal year | 2015/12 | 2014/12 | 2013/12 |
| Solvency |
-101.1%
|
25.2%
|
1.2% |
| Turnover per employee |
1
|
0 | |
| Profit as a percentage of turnover | -61900% | ||
| Return on assets (ROA) |
-142.4%
|
-61.5%
|
-16.1% |
| Current ratio |
1.8%
|
4.7%
|
107.9% |
| Return on equity (ROE) |
140.9%
|
-1719.4%
|
-1453.8% |
| Change turnover | |||
| Change turnover % |
-100%
|
150%
|
-67% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
-100%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2015/12 | 2014/12 | 2013/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.